SEROTYPE DISTRIBUTION, ANTIBIOTIC SUSCEPTIBILITY PROFILE AND MOLECULAR CHARACTERISTICS OF STREPTOCOCCUS PNEUMONIAE CAUSING INVASIVE PNEUMONIAE DISEASE AT SOME HOSPITALS IN NORTHERN VIETNAM
Main Article Content
Abstract
Objective: This study aims to identify serotype distribution of Streptococcus pneumoniae isolated from invasive pneumoniae patients at some hospitals in northern Vietnam from 2014 to 2023, and to determine molecular characteristics and antibiotic susceptibility profile of S.pneumoniae isolates. Materials and methods: This is a cross-sectional descriptive study, collecting 80 invasive pneumococcal isolates from 2014 to 2023 at some hospitals in northern Vietnam. Antimicrobial susceptibility testing was performed by disk diffusion method and Etest. Whole genome sequencing was carried out on Illumina Miseq. Results: There were 22 serotypes detected in 80 invasive pneumococcal isolates, in which the most ubiquitous serotypes included 9V, 19A, 3, 23F, 19F, 11A, 14, 6B/6E, 15A accounting for 71.3%. Seven out of these 9 serotypes were covered by vaccin PCV13. We detected 42 different MLSTs with the most prevelent sequence types such as ST10120, ST320, ST180, ST63, ST271, ST166. All S.pneumoniae isolates still maintained sensitive to levofloxacin, but high multiple drug resistance - MDR proportion (90%), and highly non-sensitive to: erythromycin (92.5%), clindamycin (92.5%), tetracycline (88.8%) and trimethoprim sulfamethoxazole (73.8%). Gene ermB mainly conferred for resistance to erythromycin and clindamycin (91.3%). Conclusions: S.pneumoniae isolates in this study carried many different serotypes and MLSTs, with high rate of MDR strains, and high percentage of resistance to erythromycin, clindamycin and tetracycline
Article Details
Keywords
Serotype, Invasive pneumoniae disease, AMR, Streptococcus pneumoniae
References


2. Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine. 2012;30(24):3503-3514. doi:10.1016/ j.vaccine.2012.03.066


3. Kim SH, Song JH, Chung DR, et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother. 2012;56(3):1418-1426. doi:10.1128/AAC.05658-11


4. Opavski N, Jovicevic M, Kabic J, et al. Serotype distribution, antimicrobial susceptibility and molecular epidemiology of invasive Streptococcus pneumoniae in the nine-year period in Serbia. Front Microbiol. 2023;14:1244366. doi:10.3389/fmicb.2023.1244366


5. Parry CM, Duong NM, Zhou J, et al. Emergence in Vietnam of Streptococcus pneumoniae Resistant to Multiple Antimicrobial Agents as a Result of Dissemination of the Multiresistant Spain23F-1 Clone. Antimicrob Agents Chemother. 2002;46(11):3512-3517. doi:10.1128/AAC.46.11.3512-3517.2002


6. Song JY, Nahm MH, Moseley MA. Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance (1). J Korean Med Sci. 2013;28(1):4. doi:10.3346/jkms.2013.28.1.4


7. Clinical and Laboratory Standards Institute (2024), Performance standards for antimicrobial susceptibility testing, CLSI supplement M100. ttps://pid-el.com/wp-content/uploads/2024/07/ CLSI-M100.pdf.

8. ECDC (2018). Invasive pneumococcal disease - Annual Epidemiological Report for 2018. https://www.ecdc.europa.eu/en/publications-data/invasive-pneumococcal-disease-annual-epidemiological-report-2018
